Skip to content
etf.net

BIB vs DDM

ProShares Ultra Nasdaq Biotechnology

BIBBNasdaq

ProShares Ultra Dow30

DDMBNYSE Arca

Overlap

Expense ratio

Same figure. Both funds show the same value, so neither comes out ahead.

BIB0.95%DDM0.95%

Avg volume · 30D

DDM 17.7×the volume

BIB10.5KDDM185K

10Y return · a year

DDM +6.6pt

BIB+12.6%DDM+19.2%

BIB vs DDM Performance

Oct 29, 2021 – Oct 30, 2026

+36.3%BIB+68.8%DDM

Oct 29, 2021 to Oct 30, 2026. BIB +36.3%. DDM +68.8%. Use the arrow keys to read each point.−50%−25%0%Oct 2021Apr 2024Oct 2026
Expense ratio
BIB 0.95%
DDM 0.95%
Fund size
BIB $104M
DDM $507M
1Y total return
BIB +68.9%, better
DDM +13.4%
Yield (12M)
BIB 0.19%
DDM 0.98%, better
Holdings
BIB 247
DDM 34
Avg volume (30D)
BIB 10.5K sh
DDM 185K sh, better
NAV per share
BIB $120.62
DDM $62.99
52W range

ETF.net Grade

BIB: Cost 51, Risk 70, Mission not scored, Tradability 84, Holdings 60, Durability 75. DDM: Cost 51, Risk 79, Mission 92, Tradability 93, Holdings 53, Durability 79.
Pillar letters and Scores for BIB, DDM, with each pillar’s weight
PillarBIBDDM
Cost30% weightC51C51
Mission25% weightNot scoredA92
Risk15% weightA70A79Higher
Tradability15% weightA84A93Higher
Holdings10% weightB60HigherC53
Durability5% weightA75A79Higher

Rank among Leveraged Long (2x & Other) funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. BIB and DDM are both graded against the same 95 Leveraged Long (2x & Other) funds, so their Grades compare head to head.

Leveraged Long (2x & Other)⁠

Category · 95 funds
See all 95 ›

DDM ranks 4th and BIB 8th of 95 funds in the Leveraged Long (2x & Other) Category.

  1. Rank 1AQLDProShares Ultra QQQScore 77
  2. Rank 2AUYGProShares Ultra FinancialsScore 74
  3. Rank 3AROMProShares Ultra TechnologyScore 71
  4. Rank 4BDDMProShares Ultra Dow30Score 69
  5. Rank 5BUSDProShares Ultra SemiconductorsScore 68
  6. Rank 7BUJBProShares Ultra High YieldScore 65
  7. Rank 8BBIBProShares Ultra Nasdaq BiotechnologyScore 64
  8. Rank 9BMVVProShares Ultra MidCap400Score 63

Our read on each fund

ETF.net Research

BIBBProShares Ultra Nasdaq Biotechnology

DDMBProShares Ultra Dow30

In short

BIB Biotech with the dial at 2x, not 3x. Since 2010 BIB has aimed at twice the daily move of the Nasdaq Biotechnology Index, a modified cap-weighted set of Nasdaq-listed biotech and pharma names, reset fresh every single day.

DDM The Dow dates to 1896. DDM is the only ETF built to double its daily move: 2x the Dow Jones Industrial Average, reset every single day, for 0.95% a year, running since 2006.

Stated mandate

BIB The Fund seeks daily investment results, before fees and expenses, that correspond to two times the daily performance of the Nasdaq Biotechnology Index.

DDM The fund seeks daily investment results, before fees and expenses, corresponding to twice the daily performance of the Dow Jones Industrial Average.

Why people hold it

  • BIB Aims for two times the daily move of the Nasdaq Biotechnology Index. Magnified biotech exposure through one ticker in a regular brokerage account, no margin agreement needed.proshares.com
  • The benchmark dates to 1993: Nasdaq-listed biotech and pharma, modified cap-weighted, roughly 300 stocks. Industry-wide exposure, not a handful of lottery tickets.nasdaqomx.comnasdaqomx.com 2
  • 0.95% net of a waiver through September 30, 2027, against a 1.17% gross. Near the category median and level with ProShares stablemate DDM at 0.95%.
  • Live since 2010 through several biotech boom-and-bust cycles, and it stands among the stronger implementations in a crowded leveraged-bull field.
  • DDM The only ETF that targets 2x the daily return of the Dow Jones Industrial Average. Leveraged blue-chip exposure through one ticker, no margin account needed.proshares.com
  • Trading since 2006, and its day-to-day results have stayed close to the 2x daily target across nearly two decades of market cycles.proshares.com
  • Easy to get in and out of for a fund its size, and one of the strongest implementations in its peer group of leveraged bull funds.
  • The 0.95% fee sits near the typical charge for leveraged funds, and it is the standing rate, not a number propped up by a temporary waiver.

Worth knowing

  • BIB Daily reset. Hold past one day and compounding takes over: returns can differ in amount, and even direction, from 2x the index over that stretch.proshares.com
  • One industry, doubled. Trial readouts and FDA decisions move biotech hard, and this fund is built to amplify those days in both directions.proshares.com
  • Among the lighter-traded, smaller funds in its category, so spreads and order size matter more here than with the headline leveraged names.
  • DDM The 2x target resets daily. Hold for weeks and compounding takes over, so results can land well away from twice the Dow's move, especially in choppy markets.proshares.com
  • The Dow is price-weighted across 30 blue chips, so a high-priced stock swings it more than a far larger company does.spglobal.com
  • Sibling leveraged funds cost a little less: QLD charges 0.89% net of a waiver through September 30, 2027, against a 0.96% gross rate.

Full BIB profile⁠

Full DDM profile⁠

BIB vs DDM Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

BIB vs DDM Cost

Same expense ratio

$17,869

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • BIB 0.95%

    $17,869

  • DDM 0.95%

    $17,869

$10,000
30 years

Cost over time

  • BIB 0.95%
  • DDM 0.95%
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530BIB $17,869DDM $17,869

Year by year

YearBIBDDM
10$1,678$1,678
20$6,322$6,322
30$17,869$17,869

Expense ratio

  • 0.95%BIB
  • 0.95%DDM
  • Middle half of Leveraged Long (2x & Other) funds
  • Median 0.95%

BIB 32nd cheapest of 95 funds

DDM 32nd cheapest of 95 funds

BIB vs DDM Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
BIB 0.19%
DDM 0.98%, better
Payout (12M)
BIB $0.22
DDM $0.62
Last payment
BIB $0.08
DDM $0.15
Ex-dividend
BIB Sep 23, 2026
DDM Sep 23, 2026
Paid on
BIB Sep 29, 2026
DDM Sep 29, 2026
Frequency
BIB Twice a year
DDM Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

BIBTwice a year · 12 paymentsAll BIB payments⁠
One bar per payment. 12 payments from 2017 to 2026 YTD. Dec 22, 2022 $0.02; Dec 20, 2023 $0.04; Mar 20, 2024 $0.04; Jun 26, 2024 $0.26; Sep 25, 2024 $0.15; Dec 23, 2024 $0.40; Mar 26, 2025 $0.13; Jun 25, 2025 $0.17; Sep 24, 2025 $0.18; Dec 24, 2025 $0.13; Mar 25, 2026 $0.0071; Sep 23, 2026 $0.08. Use the arrow keys to read each point.$0$0.252017202020232026YTD
DDMQuarterly · 33 paymentsAll DDM payments⁠
One bar per payment. 33 payments from 2017 to 2026 YTD. Mar 22, 2017 $0.04; Jun 21, 2017 $0.03; Sep 27, 2017 $0.04; Dec 26, 2017 $0.04; Mar 21, 2018 $0.03; Jun 20, 2018 $0.03; Sep 26, 2018 $0.06; Dec 26, 2018 $0.04; Mar 20, 2019 $0.04; Jun 25, 2019 $0.05; Dec 24, 2019 $0.07; Mar 25, 2020 $0.06; Jun 24, 2020 $0.0055; Dec 23, 2020 $0.02; Mar 23, 2021 $0.01; Sep 22, 2021 $0.0052; Dec 23, 2021 $0.05; Mar 23, 2022 $0.07; Jun 22, 2022 $0.04; Sep 21, 2022 $0.04; Dec 22, 2022 $0.12; Dec 20, 2023 $0.11; Mar 20, 2024 $0.12; Jun 26, 2024 $0.13; Sep 25, 2024 $0.14; Dec 23, 2024 $0.09; Mar 26, 2025 $0.13; Jun 25, 2025 $0.13; Sep 24, 2025 $0.15; Dec 24, 2025 $0.14; Mar 25, 2026 $0.16; Jun 24, 2026 $0.17; Sep 23, 2026 $0.15. Use the arrow keys to read each point.$0$0.252017202020232026YTD

BIB vs DDM Risk

Fall from peak · 5 years

  • BIB
  • DDM
Oct 29, 2021 to Oct 30, 2026. Worst fall: BIB −61.8% · Apr 2025. Use the arrow keys to read each point.−60%−40%−20%0%Oct 2021Apr 2024Oct 2026

Risk facts

VolatilityStd dev, 3 years
BIB 33.9%DDM 24.6%, better
Return per unit of riskSharpe ratio, 3 years
BIB 1.12, betterDDM 0.96
Worst fallMax drawdown, 5 years
BIB −61.8%DDM −40.2%, better
Market sensitivityBeta, 5 years
BIB 1.20DDM 1.74

Popular comparisons

  • BIBBvsQLDA

    ProShares Ultra Nasdaq Biotechnology · ProShares Ultra QQQ

    Expense ratio
    0.95% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • DDMBvsQLDA

    ProShares Ultra Dow30 · ProShares Ultra QQQ

    Expense ratio
    0.95% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • BIBBvsUYGA

    ProShares Ultra Nasdaq Biotechnology · ProShares Ultra Financials

    Expense ratio
    0.95% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • DDMBvsUYGA

    ProShares Ultra Dow30 · ProShares Ultra Financials

    Expense ratio
    0.95% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • BIBBvsROMA

    ProShares Ultra Nasdaq Biotechnology · ProShares Ultra Technology

    Expense ratio
    0.95% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • DDMBvsROMA

    ProShares Ultra Dow30 · ProShares Ultra Technology

    Expense ratio
    0.95% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.